Logo image of GDTC

CYTOMED THERAPEUTICS LTD (GDTC) Stock Analyst Ratings

USA - NASDAQ:GDTC - SGXZ17669631 - Common Stock

2.69 USD
+0.4 (+17.47%)
Last: 10/20/2025, 8:00:01 PM
2.64 USD
-0.05 (-1.86%)
After Hours: 10/20/2025, 8:00:01 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to GDTC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.1. This target is 89.59% above the current price.
GDTC was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GDTC.
In the previous month the buy percentage consensus was at a similar level.
GDTC was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

GDTC Historical Analyst RatingsGDTC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -23 -21 -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 2.695.055.105.105.25 - 87.73% 89.59% 89.59% 95.17%

Related screens

GDTC Current Analyst RatingGDTC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-10-10 Benchmark Reiterate Speculative Buy -> Speculative Buy
2024-06-11 Benchmark Reiterate Speculative Buy -> Speculative Buy
2023-12-04 Benchmark Reiterate Speculative Buy -> Speculative Buy
2023-07-21 Benchmark Initiate Speculative Buy